OHSU

International study identifies genetic markers for cancer Share This OHSU Content

Study holds tremendous implications for early detection and treatment of ovarian, breast and prostate cancer

OHSU Gynecologic oncologist, Dr. Tanja Pejovic says, "This groundbreaking study, which leveraged theOregon Ovarian Cancer Registry (OOCR), is the largest of its kind and is a result of an international collaboration of scientists. This research is a critical advancement in ovarian cancer. Because there are typically no symptoms, most women aren't diagnosed until stages 3 and 4, which greatly reduces patient survival rates. If we can diagnose and treat earlier, outcomes will be much improved."

Find the Ovarian Cancer portion of the study at:

nature
http://www.nature.com/ncomms/journal/v4/n3/full/ncomms2629.html

 

Upcoming event

Dr. Pejovic will be speaking about Ovarian Cancer at an upcoming Knight Discovery Luncheon on May 16 from noon to 1 p.m. followed by a lab tour at the Center for Health and Healing on the waterfront.

For event details, please contact Lori Slaughter at the OHSU Foundation.

Tanja Pejovic, M.D., Ph.D.

Tanja Pejovic, M.D., Ph.D. is a gynecologic oncologist and associate professor of obstetrics and gynecology, OHSU School of medicine.